Vivek Verma
University of Minnesota · 544 works · 13,918 citations · h-index 61
Top works
- Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
- Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
- Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
- A systematic review of the cost and cost‐effectiveness studies of proton radiotherapy
- A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
- Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
- Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
- Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
- Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
- Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
- Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
- A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus
- Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer
- Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer
- Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
- The Rise of Radiomics and Implications for Oncologic Management
- Trends in stereotactic body radiation therapy for stage I small cell lung cancer
- Multi‐institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors
- Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
- Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer